A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

PurposeTo accurately assess disease progression after Stereotactic Ablative Radiotherapy (SABR) of early-stage Non-Small Cell Lung Cancer (NSCLC), a combined predictive model based on pre-treatment CT radiomics features and clinical factors was established.MethodsThis study retrospectively analyzed...

Full description

Bibliographic Details
Main Authors: Hong Yang, Lin Wang, Guoliang Shao, Baiqiang Dong, Fang Wang, Yuguo Wei, Pu Li, Haiyan Chen, Wujie Chen, Yao Zheng, Yiwei He, Yankun Zhao, Xianghui Du, Xiaojiang Sun, Zhun Wang, Yuezhen Wang, Xia Zhou, Xiaojing Lai, Wei Feng, Liming Shen, Guoqing Qiu, Yongling Ji, Jianxiang Chen, Youhua Jiang, Jinshi Liu, Jian Zeng, Changchun Wang, Qiang Zhao, Xun Yang, Xiao Hu, Honglian Ma, Qixun Chen, Ming Chen, Haitao Jiang, Yujin Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
stereotactic ablative radiotherapy
progression
radiomics
predictive model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.967360/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.967360/full

Similar Items